Cough·7: Current and future drugs for the treatment of chronic cough

Thorax

Volumn 59, Issue 5, 2004, Pages 438-440

  Belvisi, M G ^a   Geppetti, P ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ANTITUSSIVE AGENT; BENZONATATE; BRADYKININ ANTAGONIST; CHLORIDE CHANNEL; CODEINE; DEXTROMETHORPHAN; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOMORPHIN 1; ENDOMORPHIN 2; FUROSEMIDE; INDOMETACIN; LEVDROPROPIZINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MENTHOL; MORPHINE; NOCICEPTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXALAMINE; OZAGREL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; PRENOXDIAZINE; PROTON PUMP INHIBITOR; SAREDUTANT; SB 235375; TACHYKININ RECEPTOR ANTAGONIST; THROMBOXANE SYNTHASE INHIBITOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; TREATMENT INDICATION; CHRONIC DISEASE; FORECASTING; PHARMACEUTICS;

ANTITUSSIVE AGENTS; CHRONIC DISEASE; COUGH; FORECASTING; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 2442433528     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.013490     Document Type: Review

References (30)

1. Choudry NB, Fuller RW. Sensitivity of the cough reflex in patients with chronic cough. Eur Respir J 1992;5:296-300.
2. Karlsson J-A, Sant'Ambrogio G, Widdicombe J. Afferent neural pathways in cough and reflex bronchoconstriction. J Appl Physiol 1988;65:1007-23.
3. Schroeder K, Fahy T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ 2002;324:1-6.
4. MacRedmond R, O'Connell F. Treatment of persistent dry cough: if possible, treat the cause; if not, treat the cough. Monaldi Arch Chest Dis 1999;3:269-74.
5. Daona M, Walsh D. Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med 1998;12:55-8.
6. Homsi J, Walsh D, Nalson KA. Important drugs for cough in advanced cancer. Support Care Cancer 2001;9:565-74.
7. Choudry NB, Fuller RW, Anderson N, et al. Separation of cough and reflex bronchoconstriction by inhaled local anaesthetics. Eur Respir J 1990;3:579-83.
8. Morice AH, Marshall AE, Higgins KS, et al. Effect of inhaled menthol on citric acid induced cough in normal subjects. Thorax 1994;49:1024-6.
9. Sant'Ambrogio FB, Anderson JW, Sant'Ambrogio G. Effect of L-menthol on laryngeal receptors. J Appl Physiol 1991;70:788-93.
10. Groneberg D, Fischer A. Endogenous opioids as mediators of asthma. Pulmonol Pharmacol 2001;14:383-9.
11. Fischer A, Forssman WG, Undem BG. Nociceptin induced inhibition of tachykinergic neurotransmission in guinea-pig bronchus. J Pharmacol Exp Ther 1998;285:902-7.
12. Shah D, Page CP, Spina D. Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol 1998;125:510-6.
13. Advenier C, Girard V, Naline E, et al. Antitussive effect of SR 48968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol 1993;250:169-71.
14. Girard V, Naline E, Vilain P, et al. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetised guinea-pig. Eur Respir J 1995;8:1110-4.
15. Daoui S, Cognon C, Naline E, et al. Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea-pigs. Am J Respir Crit Care Med 1998;158:42-8.
16. Hay DWP, Giardina GAM, Griswold DE, et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin 3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea-pigs. J Pharmacol Exp Ther 2002;300:314-23.
17. Choudry NB, Fuller RW, Pride NB. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 1989;140:137-41.
18. Fox AJ, Lalloo UG, Belvisi MG, et al. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 1996;2:814-7.
19. Mukae S, Aoki S, Itoh S, et al. Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough. Hypertension 2000;36:127-31.
20. Costello JF, Dunlop LS, Gardiner PJ. Characteristics of prostaglandin induced cough in man. Br J Clin Pharmacol 1985;20:355-9.
21. Fujimura M, Kamio Y, Kasahara K, et al. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995;8:1499-505.
22. Fogari R, Zoppi A, Tettamanti F, et al. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Caraiovasc Pharmacol 1992;19:670-3.
23. Malini PL, Strocchi E, Zanardi M, et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997;350:15-18.
24. McEwan JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther 1990;255:161-4.
25. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002;416:52-8.
26. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature 1997;389:816-24.
27. Caterina MJ, Leffler A, Malmberg AG, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:306-13.
28. Fox AJ, Barnes PJ, Venkatesan P, et al. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea-pig. J Clin Invest 1997;99:513-9.
29. + channel openers. Eur J Pharmacol 1999;371:39-42.
30. 2 alpha. Br J Clin Pharmacol 1992;33:514-6.